Evaluate bolsters custom services capabilities to meet growing demand for expert analytical and data services

Paul Verdin joined Evaluate in 2015 to head up Custom Services and its dedicated analyst and technical team. Paul was previously at Thomson Reuters, where he played a key role in building the Life Sciences Professional Services organisation. He is supported by Jon Moser, Services Delivery Lead. Jon has deep industry and Evaluate data expertise, having developed and shaped the EvaluatePharma® subscription service since 2004.

Evaluate’s Custom Services couple our deep industry expertise with our life science market intelligence, evaluation tools and forecasts. Frameworks and deliverables are designed in collaboration with our clients to maximise the value of our data, drive actionable insights, and help our clients solve their specific business problems”, said Paul Verdin.

Some examples of the types of services offered include:

  • Custom datasets based fully or partially on existing Evaluate content, aggregated, manipulated, and extended according to client needs
  • Analytical solutions combining Evaluate content, targeted external research, industry expertise, and our structured and tailored methodologies
  • Data management services to provide our clients with the right information, at the right time, and in the right format

To learn more about the Evaluate Custom Services please visit www.evaluate.com/customservices

About Evaluate Ltd

Evaluate is the trusted provider of commercial intelligence including product sales and consensus forecasts to 2022 for commercial teams and their advisors within the global life science industry.

We help our clients make high value decisions through superior quality, timely, must-have data and insights, combined with personalised, expert client support.

Our online subscription services cover the pharmaceutical, biotech and medtech sectors. Our Custom Services group delivers project based analytical and data services.

Vantage – our independent and award-winning editorial team – offers data-driven, forward-looking news, commentary and analysis on a daily basis.

For more information visit: www.evaluate.com or follow @EvaluatePharma on Twitter.

Media Contacts

Jennifer Dinkel
General questions

Instinctif Partners
Non-U.S. media